Influence of renal failure on the disposition of morphine, morphine-3-glucuronide and morphine-6-glucuronide in sheep during intravenous infusion with morphine

被引:0
|
作者
Milne, RW
McLean, CF
Mather, LE
Nation, RL
Runciman, WB
Rutten, AJ
Somogyi, AA
机构
[1] FLINDERS MED CTR,DEPT ANAESTHESIA & INTENS CARE,ADELAIDE,SA,AUSTRALIA
[2] ROYAL ADELAIDE HOSP,DEPT ANAESTHESIA & INTENS CARE,ADELAIDE,SA 5000,AUSTRALIA
[3] UNIV ADELAIDE,DEPT CLIN & EXPT PHARMACOL,ADELAIDE,SA,AUSTRALIA
[4] UNIV SYDNEY,DEPT ANAESTHESIA & PAIN MANAGEMENT,SYDNEY,NSW 2006,AUSTRALIA
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The influence of experimentally induced renal failure on the disposition of morphine, morphine-3-glucuronide (M3G) and morphine-6-glucuronide (M6G) was examined in seven sheep infused intravenously with morphine for 6 hr. Between 5 and 6 hr, blood was collected from the aorta, pulmonary artery, hepatic, hepatic portal and renal veins and posterior vena cava. Additional samples from the aorta and urine were collected up to 144 hr. Morphine, M3G and M6G were determined in plasma and urine by high-performance liquid chromatography. Constant concentrations of morphine, but not of M3G and M6G, were achieved in plasma between 5 and 6 hr. Significant (P < .001) extraction of morphine by the liver (0.72 +/- 0.05) and kidney (0.42 +/- 0.15) occurred. Compared with sheep with normal kidneys (Milne et al., 1995), renal failure did not alter (P =.11) the mean total clearance of morphine (1.5 +/- 0.3 liters/min); clearance by the kidney was less (P <.001). However, a paired comparison using sheep common to this study and from the study when their kidneys were normal revealed a significant reduction in mean total clearance of 25%. The renal extraction of M3G and M6G and urinary recovery of the dose as summed morphine, M3G and M6G were reduced by renal failure. The kidney metabolized morphine to M3G. The data suggest that nonrenal elimination of M3G becomes more important during renal failure.
引用
收藏
页码:779 / 786
页数:8
相关论文
共 50 条
  • [41] Deep proteomics and phosphoproteomics reveal novel biological pathways perturbed by morphine, morphine-3-glucuronide and morphine-6-glucuronide in human astrocytes
    Dozio, Vito
    Daali, Youssef
    Desmeules, Jules
    Sanchez, Jean-Charles
    JOURNAL OF NEUROSCIENCE RESEARCH, 2022, 100 (01) : 220 - 236
  • [42] DETERMINATION OF MORPHINE AND MORPHINE-3-GLUCURONIDE IN SERUM
    VANDENBERGHE, HM
    SOLDIN, SJ
    CLINICAL BIOCHEMISTRY, 1982, 15 (02) : 98 - 98
  • [43] MORPHINE-3-GLUCURONIDE MAY FUNCTIONALLY ANTAGONIZE MORPHINE-6-GLUCURONIDE INDUCED ANTINOCICEPTION AND VENTILATORY DEPRESSION IN THE RAT
    GONG, QL
    HEDNER, J
    BJORKMAN, R
    HEDNER, T
    PAIN, 1992, 48 (02) : 249 - 255
  • [44] Effect of prior morphine-3-glucuronide exposure on morphine disposition and antinociception
    Ouellet, DMC
    Pollack, GM
    BIOCHEMICAL PHARMACOLOGY, 1997, 53 (10) : 1451 - 1457
  • [45] Comparison of the disposition of hepatically-generated morphine-3-glucuronide and morphine-6-glucuronide in isolated perfused liver from the guinea pig
    Milne, RW
    Jensen, RH
    Larsen, C
    Evans, AM
    Nation, RL
    PHARMACEUTICAL RESEARCH, 1997, 14 (08) : 1014 - 1018
  • [46] Comparison of the Disposition of Hepatically-Generated Morphine-3-glucuronide and Morphine-6-glucuronide in Isolated Perfused Liver from the Guinea Pig
    Robert W. Milne
    Rikke Holm Jensen
    Claus Larsen
    Allan M. Evans
    Roger L. Nation
    Pharmaceutical Research, 1997, 14 : 1014 - 1018
  • [47] MORPHINE, MORPHINE-6-GLUCURONIDE AND MORPHINE-3-GLUCURONIDE CONCENTRATIONS IN PLASMA AND CEREBROSPINAL-FLUID DURING LONG-TERM HIGH-DOSE INTRATHECAL MORPHINE ADMINISTRATION
    BIGLER, D
    CHRISTENSEN, CB
    ERIKSEN, J
    JENSEN, NH
    PAIN, 1990, 41 (01) : 15 - 18
  • [48] Cerebrospinal fluid and plasma concentrations of morphine, morphine-3-glucuronide, and morphine-6-glucuronide in patients before and after initiation of intracerebroventricular morphine for cancer pain management
    Smith, MT
    Wright, AWE
    Williams, BE
    Stuart, G
    Cramond, T
    ANESTHESIA AND ANALGESIA, 1999, 88 (01): : 109 - 116
  • [49] Plasma concentrations of morphine, morphine-6-glucuronide and morphine-3-glucuronide and their relationship with analgesia and side effects in patients with cancer-related pain
    Quigley, C
    Joel, S
    Patel, N
    Baksh, A
    Slevin, M
    PALLIATIVE MEDICINE, 2003, 17 (02) : 185 - 190
  • [50] Routine drug monitoring of serum concentrations of morphine, morphine-3-glucuronide and morphine-6-glucuronide do not predict clinical observations in cancer patients
    Klepstad, P
    Borchgrevink, PC
    Dale, O
    Zahlsen, K
    Aamo, T
    Fayers, P
    Fougner, B
    Kaasa, S
    PALLIATIVE MEDICINE, 2003, 17 (08) : 679 - 687